Supreme Court Allows Trump Administration to Proceed with Mail-In Voting Restrictions Before Midterms
The Supreme Court lifted a lower court block on the Trump administration's mail-in voting restrictions, allowing enforcement to proceed in 23 states ahead of November midterms, though U.S. Postal Service implementation remains separately blocked.The Supreme Court issued an unsigned order allowing the Trump administration to move forward with new restrictions on mail-in voting, pausing a lower court ruling that had blocked key parts of the policy. The decision clears the path for enforcement in 23 states ahead of November's midterm elections, though a separate block on U.S. Postal Service implementation of the order remains in place nationwide.
The court's order was not accompanied by a full written opinion. Justice Ketanji Brown Jackson wrote a dissent, arguing the ruling introduces uncertainty into the upcoming elections at a late stage. The ideological split among justices was apparent, though the majority's reasoning was not publicly detailed.
Practical implementation faces significant time pressure. Some states are scheduled to begin mailing ballots to voters within weeks, leaving a narrow window for any meaningful changes to take effect. The Postal Service had outlined an implementation plan last week, but that portion of the order remains under a separate court-ordered hold.
The administration's original executive order sought to tighten the conditions under which mail ballots could be requested, distributed, or counted. Courts at the district level had blocked portions of the order on constitutional grounds. The Supreme Court's intervention is not a final ruling on the merits — it allows enforcement to continue while legal challenges proceed through the courts.
The decision is likely to affect voter access in states that had expanded mail-in voting in recent election cycles. Legal challenges are ongoing, and further court rulings before November are possible. Election administrators in affected states are now navigating uncertainty over which rules will apply.
Trump Administration Moves Toward Largest Mass Visa Revocation in U.S. History
The Trump administration is preparing to revoke visas for up to 200,000 foreign nationals who have applied for or are currently seeking asylum status in the United States. Separately, a federal judge vacated a related visa freeze covering 75 countries.The Trump administration is preparing what officials describe as the largest mass visa revocation in American history, targeting up to 200,000 foreign nationals who have applied for or are currently in the process of seeking asylum in the United States. The action would affect individuals who entered the country on nonimmigrant visas and subsequently filed asylum claims.
The planned revocation is separate from an earlier executive order by Secretary of State Marco Rubio that imposed a visa freeze on nationals from 75 countries. A federal judge vacated that freeze, ruling against the administration's legal basis for the measure. State Department officials publicly criticized the ruling, characterizing the judge as acting outside appropriate judicial boundaries.
The administration has not set a specific public date for the mass revocation, but officials indicated the process is in an advanced stage of preparation. The legal authority and procedural mechanisms for revoking visas at this scale are expected to face court challenges.
These immigration enforcement actions are taking place alongside a broader pattern of measures including an ICE operation in Virginia and Maryland that resulted in 1,328 arrests over a 14-day period. The administration has described these as part of a sustained enforcement campaign rather than isolated operations.
The visa revocation plan would have significant implications for immigration courts, which are already operating under a substantial backlog. Affected individuals would likely have limited time to respond or seek legal relief.
Nevada Sues Trump Administration Over Colorado River Water Use Cuts
Nevada filed a federal lawsuit challenging the Trump administration's Colorado River management plan, which would reduce water allocations to California, Arizona, and Nevada by roughly 20% over two years. The river supplies water to 40 million people across the American West.Nevada filed a federal lawsuit seeking to block the Trump administration's new management plan for the Colorado River, which would reduce water allocations to California, Arizona, and Nevada by approximately 20% over a two-year period. Nevada is the first state to sue over the plan, but officials and legal observers expect additional lawsuits from other affected states and stakeholders.
The Colorado River is the primary water source for 40 million people, dozens of tribal nations, and approximately 5.5 million acres of farmland across the American West and Southwest. The river has been under severe stress for decades due to drought, overuse, and rising temperatures, with reservoir levels at major storage facilities remaining well below historical norms.
The Trump administration's plan represents one approach to bringing water consumption into balance with actual river flows, which have declined significantly due to climate-related changes in precipitation and snowpack. States and water agencies have long disagreed over how to apportion the necessary reductions.
Nevada's lawsuit argues the administration's plan exceeds federal authority or violates existing legal agreements governing water allocation. The case enters a complex legal landscape shaped by interstate compacts, tribal water rights, and decades of court rulings.
The outcome will have direct consequences for municipal water supplies, agriculture, and economic activity across a region that has experienced rapid population growth in recent decades. Legal proceedings are expected to continue for months or years.
Trade negotiations between the U.S. and Canada fell apart, with the Trump administration imposing 50% tariffs on some Canadian goods and threatening further increases on cars, auto parts, and steel beginning January 1. Canada pledged dollar-for-dollar retaliatory tariffs.U.S.-Canada trade negotiations collapsed, triggering an escalation from both governments. The Trump administration imposed 50% tariffs on certain Canadian goods and announced plans to raise tariffs on cars, trucks, auto parts, and steel to 50% starting January 1. President Trump indicated additional measures could follow if talks do not resume on favorable terms.
Canadian Prime Minister Mark Carney pledged to respond with retaliatory tariffs on U.S. exports on a dollar-for-dollar basis. As part of the now-failed proposed deal, Carney had asked Canadian provinces to lift their boycotts on American alcohol products, which had been introduced earlier in the year. Those boycotts remain in place.
The breakdown marks a significant deterioration in relations between the two countries, which share one of the world's largest bilateral trading relationships. Canada's retaliatory posture has drawn positive signals from China and reportedly exposed internal disagreements within the Trump administration over how to proceed.
The dispute carries direct implications for American consumers and businesses. Auto manufacturers with cross-border supply chains face potential cost increases. Sectors including agriculture, lumber, and energy are also exposed to disruption from retaliatory measures.
Both governments have left open the possibility of resumed talks, but no new negotiating sessions have been announced. The January 1 deadline for additional U.S. tariff increases gives both sides roughly four months to reach a revised framework before another escalation takes effect.
Nearly 40,000 Bottles of Clear Eyes Maximum Itchy Eye Relief Recalled Over Sterility Concerns
The maker of Clear Eyes Maximum Itchy Eye Relief voluntarily recalled nearly 40,000 bottles after federal regulators cited a lack of assurance of sterility in the product.Federal safety regulators announced a voluntary recall of approximately 40,000 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops, citing a lack of assurance that the product meets sterility standards. The recall was initiated by the manufacturer in response to concerns raised by the U.S. Food and Drug Administration.
The specific concern is sterility assurance — meaning the manufacturer could not confirm that the product was free from microbial contamination during production. Non-sterile eye drops pose a risk of eye infection, which in severe cases can lead to vision damage.
Consumers who have purchased Clear Eyes Maximum Itchy Eye Relief should check the product against recall information available from the FDA and stop using it if it is covered by the recall. The recall applies to a specific lot or lots; consumers are advised to check the FDA's website for the exact batch numbers affected.
Researchers and Patients Challenge Whether FDA-Approved Cancer Drug Doses Are Too High
Researchers and patients are raising questions about whether FDA-approved dosages for certain cancer drugs are higher than necessary, with some arguing that lower doses could reduce side effects without compromising effectiveness.A growing body of research and patient advocacy is challenging the standard practice of approving maximum tolerated doses for cancer drugs, with some economists and medical researchers arguing that many FDA-approved dosages may be higher than required for therapeutic effect. The concern is that patients receive doses calibrated to the edge of tolerability, producing severe side effects, when lower doses might achieve similar outcomes with fewer harms.
Northwestern University economist Chuck Manski is among those who have examined the issue. The argument centers on the clinical trial design process: early-phase cancer trials typically identify the highest dose patients can endure, which then becomes the approved dose. Critics argue this approach prioritizes maximum biological effect over patient quality of life.
Patients who have experienced significant side effects from standard dosing have joined researchers in calling for trials that systematically test lower doses. Some oncologists already adjust doses in practice for individual patients, but formal lower-dose approvals are rare. The FDA has in recent years signaled openness to so-called dose optimization studies, but the pace of change has been gradual.
Stories of tragedy and violence — expand only if you choose to
Landfill Collapse in Guinea Kills at Least 30 After Heavy Rain
A large garbage heap collapsed onto residential structures near a landfill in Conakry, Guinea, following heavy rain, killing at least 30 people. Rescue operations were underway to search for survivors.A garbage heap at a major landfill site in Conakry, the capital of Guinea, collapsed onto nearby homes following heavy rainfall, killing at least 30 people. Rescue workers were searching for additional survivors in the debris. The collapse buried residential structures adjacent to the landfill site. Landfill collapses are a recurring hazard in rapidly urbanizing areas where informal settlements develop near waste disposal sites with inadequate structural monitoring.